ATLANTA, Ga.–(BUSINESS WIRE)–Renowned national medical aesthetics enterprise OVME (pronounced “of me”), which is backed by VMG Partners, announces the hire of Kevin Keith as Chief Marketing Officer to its Executive Leadership Team. In this new role, Keith will be responsible for scaling and significantly growing all lines of revenue for OVME’s retail studios and e-commerce … [Read more…]
CHICAGO–(BUSINESS WIRE)–Molina Healthcare of Illinois (“Molina”) announced a $100,000 MolinaCares Community Service Scholarship Program designed to reward students enrolled in a college, university, vocational school, or technical institution for service to their community. “Molina is proud to salute those who help lift community members in need,” said Matt Wolf, plan president of Molina Healthcare of … [Read more…]
Empowering Women in Leadership Roles in the Medical Device, Diagnostics, and Digital Health Industries BOSTON–(BUSINESS WIRE)–MedExecWomen, a fast-growing organization dedicated to empowering women in leadership roles in medical device, diagnostics, drug delivery, and digital healthcare, announced today their third annual event will take place on June 14, 2022, in Boston. Attendance is limited to 150 … [Read more…]
Malek Faham promoted to Chief Scientist FOSTER CITY, Calif.–(BUSINESS WIRE)–Illumina Ventures, today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles Lin, PhD, has joined the team as a Principal, and Dave Johnson, PhD, has joined as … [Read more…]
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate at the 2022 Jefferies Healthcare Conference held on June 8, 2022 in New York City. Mr. Patel will also be hosting a presentation which will begin at 8:00 … [Read more…]
FORT LEE, N.J.–(BUSINESS WIRE)–Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI), Rensselaer, New York, today announced transplantation of the cell product RPESC-RPE-4W into the first participant with dry age-related macular degeneration (dry AMD) in its Phase 1/2a clinical trial (NCT04627428) being conducted … [Read more…]
Conversational AI Pioneer Announces Executive Promotions Due to Continued Growth AKRON, Ohio–(BUSINESS WIRE)–Drips is pleased to announce the recent promotion of two of its top-level executives. In the past 12 months, Drips made tremendous strides in capturing market opportunities in key verticals such as healthcare, insurance, and financial services. The Drips team grew from 90 … [Read more…]
Selection Follows Post-Hoc Analysis Demonstrating Statistical Significance of Reproxalap Over Vehicle in Ocular Redness in Completed TRANQUILITY Trial LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the designation of Schirmer test, a measure of tear production, as the sole primary endpoint in the Phase 3 TRANQUILITY-2 clinical trial of reproxalap in patients with … [Read more…]
BRIDGEWATER, N.J. & VADODARA, India–(BUSINESS WIRE)–#abreva–Cosette Pharmaceuticals, Inc (“Cosette”), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (“Alembic”; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva® (Docosanol cream 10%) in a 2 gm tube … [Read more…]
– Lumasiran Demonstrated Evidence of Improvements in Exploratory Endpoints of Systemic Oxalosis, Including Echocardiographic Structure and Function, Nephrocalcinosis, and Kidney Stone Events – – Expands Upon Previously Reported Reductions in Plasma Oxalate in PH1 Patients with Severe Renal Impairment – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new … [Read more…]
